PQ 417
417. Deputy Dara Calleary asked the Minister for Health if further consideration has been given to making the life enhancing drug Nivolumab-Opdivo available to cancer patients; the discussions his Department has had with the HSE regarding the benefits of this new drug for cancer patients; and if he will make a statement on the matter. [8242/17]
Introduced
21 February 2017
Last action
—
Status
written
Sponsors
—
Subjects
Discovery layer
Source updated
21 February 2017
Summary
417. Deputy Dara Calleary asked the Minister for Health if further consideration has been given to making the life enhancing drug Nivolumab-Opdivo available to cancer patients; the discussions his Department has had with the HSE regarding the benefits of this new drug for cancer patients; and if he will make a statement on the matter. [8242/17]
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
1 official file
Medicinal Products Availability
Medicinal Products Availability
xml · EN · 21 February 2017
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.oireachtas.ie/en/debates/question/2017-02-21/417/
- Open data entity: https://data.oireachtas.ie/ie/oireachtas/question/2017-02-21/pq_417